THERAKOS DEVELOPMENT LIMITED

FDA Regulatory Profile

THERAKOS DEVELOPMENT LIMITED appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-1822-2026, Class II) was initiated on May 16, 2025.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-1822-2026Class IIBrand Name: Cellex Photopheresis System Product Name: CELLEX Photopheresis Kit Model/Catalog NumbeMay 16, 2025